268 related articles for article (PubMed ID: 12113871)
1. The expanding role of fluoroquinolones.
Schaeffer AJ
Am J Med; 2002 Jul; 113 Suppl 1A():45S-54S. PubMed ID: 12113871
[TBL] [Abstract][Full Text] [Related]
2. The expanding role of fluoroquinolones.
Schaeffer AJ
Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women.
Garrison J; Hooton TM
Expert Opin Pharmacother; 2001 Aug; 2(8):1227-37. PubMed ID: 11584990
[TBL] [Abstract][Full Text] [Related]
4. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
5. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
Blondeau JM
Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Hansen GT; Blondeau JM
J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
[TBL] [Abstract][Full Text] [Related]
7. Comparison of enoxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with complicated urinary tract infection.
Gottlieb PL
Clin Ther; 1995; 17(3):493-502. PubMed ID: 7585853
[TBL] [Abstract][Full Text] [Related]
8. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis.
Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY
Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial agents for treating uncomplicated urinary tract infection in women.
Zalmanovici Trestioreanu A; Green H; Paul M; Yaphe J; Leibovici L
Cochrane Database Syst Rev; 2010 Oct; (10):CD007182. PubMed ID: 20927755
[TBL] [Abstract][Full Text] [Related]
12. Addressing antibiotic resistance.
Gupta K
Dis Mon; 2003 Feb; 49(2):99-110. PubMed ID: 12601340
[TBL] [Abstract][Full Text] [Related]
13. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.
Richard GA; Mathew CP; Kirstein JM; Orchard D; Yang JY
Urology; 2002 Mar; 59(3):334-9. PubMed ID: 11880065
[TBL] [Abstract][Full Text] [Related]
14. Urinary tract infection: traditional pharmacologic therapies.
Nicolle LE
Am J Med; 2002 Jul; 113 Suppl 1A():35S-44S. PubMed ID: 12113870
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.
Talan DA; Krishnadasan A; Abrahamian FM; Stamm WE; Moran GJ;
Clin Infect Dis; 2008 Nov; 47(9):1150-8. PubMed ID: 18808361
[TBL] [Abstract][Full Text] [Related]
16. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
17. Quinolones for uncomplicated acute cystitis in women.
Rafalsky V; Andreeva I; Rjabkova E
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD003597. PubMed ID: 16856014
[TBL] [Abstract][Full Text] [Related]
18. [Role of levofloxacin in the treatment of urinary tract infections].
Trinchiere A
Arch Ital Urol Androl; 2001 Jun; 73(2):105-13. PubMed ID: 11758533
[TBL] [Abstract][Full Text] [Related]
19. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis.
McKinnell JA; Stollenwerk NS; Jung CW; Miller LG
Mayo Clin Proc; 2011 Jun; 86(6):480-8. PubMed ID: 21576512
[TBL] [Abstract][Full Text] [Related]
20. Management of urinary tract infections: historical perspective and current strategies: Part 2--Modern management.
Nickel JC
J Urol; 2005 Jan; 173(1):27-32. PubMed ID: 15592019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]